+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Animal Testing And Non-Animal Alternative Testing Global Market Opportunities And Strategies To 2035

  • PDF Icon

    Report

  • 306 Pages
  • July 2022
  • Region: Global
  • The Business Research Company
  • ID: 5010747
This report describes and evaluates the animal testing and non-animal alternative testing market in major geographies.

Animal testing or experiment on animals done in the early stages of drug development and for toxicity and safety assessment of medical devices, chemicals, pesticides, cosmetics, and food compounds. Animal experiments are necessary before testing on humans mainly to evaluate toxicity, pharmacokinetics, and safety of a drug or a chemical. However, there is an increasing pressure from the animal welfare organizations on governmental agencies and companies to use non-animal alternative testing technologies. These technologies include in-vitro cell and tissue cultures, organ-on-chip, computer simulations, 3D bio printing of tissues, and synthetic skin substitutes, among others. Industries such as pharmaceuticals, medical devices, chemicals & pesticides and food are increasingly adopting these technologies to replace animal testing.

Animal Testing

The global animal testing market was valued at $10.74 billion in 2019 and the market is expected to grow at a compound annual growth rate (CAGR) of 4.27% during 2019-2025 and at a CAGR of 2.46% during 2025-2035. USA and Japan are the major animal testing markets in the world. The USA’s animal testing market was valued at $4.67 billion in 2019, and is expected to grow at a CAGR of 1.49% during 2019-2025 and at a CAGR of 0.57% during 2025-2035. Japan’s animal testing market was valued at $1.03 billion in 2019. The market is forecast to grow at a CAGR of 3.51% during 2019-2025, and at a CAGR of 1.73% during 2025-2035.

The growth of the animal testing market in the USA and Japan is mainly due to the rise in R&D activities in end-use industries, and regulations to conduct animal experiments before testing on humans. However, the slow anticipated future growth rates (from 2021 to 2035) can be attributed to the requirement from federal agencies on biopharma companies to adopt 3R principles (i.e. to replace, reduce, and refine animals used in the laboratory research), protests from animal welfare organizations. In 2021, the US Environmental Protection Agency (EPA) decided to rule out mammal testing for chemicals by 2035, and increasing preference by end-use industries towards the adoption of non-animal testing technologies.

Non-Animal Testing

The global non-animal alternative testing market was valued at $1.110 billion in 2019. The market is expected to grow at a CAGR of 10.40% during 2019-2025. The USA’s non-animal alternative testing technology market was valued at $0.336 billion in 2019. The USA’s market is forecast to grow at a CAGR of 11.99% through 2025. Japan's non-animal alternative testing technology market was valued at $0.058 billion in 2019 and the market is forecast to grow at a CAGR of 6.79% through 2025.

The growth in the non-animal alternative testing market is mainly due to the adoption of the 3R principles by both regulatory agencies, and end-use companies, especially in the cosmetic industry. The adoption of alternative technologies is expected to grow after 2026 post regulatory agencies’ validation and approval.

The non-animal alternative testing market trends in the USA and Japan include raising investment for the development of alternatives to animal testing technologies, increasing adoption of in-vitro and in-silico technologies by the pharmaceutical industry, and the use of non-animal testing methods in the cosmetics industry.

The major drivers of the non-animal alternative testing technologies market include technological advances in drug development, ethical concerns on animal experimentations, high costs of animal studies, government programs for non-animal testing, rise in the number of research and development activities, raising investments and research grants for developing alternative technologies, increasing collaborations and partnerships to reduce animal testing, non-animal testing methods in the cosmetics industry are gaining traction, and increasing social awareness against animal cruelty. Factors that could hinder the growth of the non-animal testing include regulatory mandate on animal testing for drug/medical device approval, limitations in in-vitro testing technologies, and a lack of predictive ability of in-vitro testing over in-vivo testing.

The non-animal alternative testing market is fragmented with major developers contributing to around 15-20% of the total market in 2020. Some of the major developers of alternative testing technologies in the USA include Emulate Inc, Organovo Holdings, MatTek Corporation & EMD Millipore. The major Japanese developers include J-TEC, Reprocell Inc. and Organ Technologies.

Comparative Analysis And Regulatory Landscape

Animal tests including genetic toxicity, eye irritation, skin corrosion, skin sensitivity, and others are costlier when compared to non-animal testing technologies. High costs of animal testing include the cost of the animal, and the animal testing operation costs such as maintenance of animals and cost for human resource personnel. Considering all these, the costs for animal testing methods are higher than non-animal alternative testing methods.

In the USA, there are several regulatory agencies including the US Public Health Service, USDA, IACUS, AAALAC, and EPA that are responsible for animal research and welfare. Regulatory agencies for cosmetics have not mandated animal testing in the USA. However, all other industries including pharmaceuticals, medical devices, chemicals, and pesticides require animal testing for new drugs/chemicals before regulatory approval. In Japan, several regulatory agencies including the ministry of environment, MHLW, MEXT, and MAFF are responsible for conducting animal experiments. Companies in Japan are also trying to follow 3R principles from a legal, ethical and scientific point of view.

Alternative Testing Technologies In End Use Industries

Companies in the USA and Japan are developing alternative testing technologies such as cell and tissue culture (in-vitro), organ-on-chip, and in-silico technologies. Cosmetics and bio-pharma industries use these technologies to evaluate toxicity, efficacy, pharmacokinetics, and safety of a drug or a chemical. These technologies vary by the accuracy in drug screening and selection, efficacy, cost and time of the test results. Alternative technologies are widely adopted by cosmetic companies to understand eye irritation, skin irritation and safety studies of chemicals.

The cosmetics segment occupies the major market share in the alternative testing market followed by the medical devices and pharma industries. This is mainly due to the preference of choosing non-animal technologies by cosmetic companies due to several reasons such as potential cost savings, changing attitudes of consumers, and regulatory changes.

There is a need for validated non-animal alternatives for pharma and other end-use industries; hence, the non-animal alternative testing technology developers should focus on getting OECD approval for their developed technologies. The adoption rate of non-animal alternative testing technologies will be high in developed countries compared to emerging nations; hence, non-animal alternative testing technology developers should focus initially on developed markets. These developers should collaborate with animal welfare organizations for better promotion of their products.

To take advantage of the opportunities, the publisher reccomends the animal testing and non-animal alternative testing companies to focus on development of 3d-printed organs for testing, focus on development of OOC (organ-on-chip) for testing, focus on pricing based on economies, provide competitively priced offerings, focus on developing economies, expand in developed markets, continue to focus on business-to-business (B2B) promotions and collaborate with end-user companies.
Frequently Asked Questions about the Global Animal Testing And Non-Animal Alternative Testing Market

What is the estimated value of the Global Animal Testing And Non-Animal Alternative Testing Market?

The Global Animal Testing And Non-Animal Alternative Testing Market was estimated to be valued at $11.68 Billion in 2021.

What is the growth rate of the Global Animal Testing And Non-Animal Alternative Testing Market?

The growth rate of the Global Animal Testing And Non-Animal Alternative Testing Market is 3.0%, with an estimated value of $17.6 Billion by 2035.

What is the forecasted size of the Global Animal Testing And Non-Animal Alternative Testing Market?

The Global Animal Testing And Non-Animal Alternative Testing Market is estimated to be worth $17.6 Billion by 2035.

Who are the key companies in the Global Animal Testing And Non-Animal Alternative Testing Market?

Key companies in the Global Animal Testing And Non-Animal Alternative Testing Market include Cyprotex, Bio, Rad Laboratories, Inc., MatTek Corporation and BioIVT.

Table of Contents

1. Animal Testing And Non-Animal Alternative Testing Market Executive Summary2. Table of Contents3. List of Figures4. List of TablesReport Structure
6. Introduction
6.1. Segmentation By Geography
6.2. Segmentation By End User Industry
7. Animal Testing And Non-Animal Alternative Testing Market Characteristics
7.1.1. Animal Testing
7.1.2. Non-Animal Alternative Testing
7.1.3. Facts About Animals In Research - Functional Resemblances Of Animals To Human Body
7.2. Animal Testing And Non-Animal Alternative Testing Market Segmentation By End-Use Industry
7.2.1. Pharmaceutical Industry
7.2.2. Academic Industry
7.2.3. Medical Devices
7.2.4. Chemicals And Pesticides Industry
7.2.5. Cosmetics
7.2.6. Others
8. Animal Testing And Non-Animal Alternative Testing Market, Value Chain Analysis
8.1.1. Animal Breeders and Suppliers
8.1.2. Non-Animal Alternative Testing Technology Developers
8.1.3. Regulatory Authorities
8.1.4. Alternative Testing Service Providers
8.1.5. End-Use Industries
9. Non-Animal Alternative Testing Trends
9.1. Development In OOC (organ-on-chip) For Testing
9.2. Adoption Of Human Patient Simulators For Testing
9.3. Focus On Development Of 3D-Printed Organs For Testing
10. Cost Analysis For Animal Testing And Alternative Technologies
10.1.1. Average Cost Of Laboratory Animals
10.1.2. Average Cost Of Non-Animal Alternative Testing Methods
10.1.3. Comparative Cost Analysis For Animal Testing And Alternative Methods
10.2. Costs Involved In Animal Testing, 2021
11. Animal Testing And Non-Animal Alternative Testing Market Segments
11.1. By End Use Industrial Application
11.1.1. Important Areas of Use
11.1.2. Basic Research
11.1.3. Applied Research
11.1.4. Regulatory Testing
11.1.5. Development Of New Diagnostic Methods
11.1.6. Breeding Of Genetically Altered Animals
11.1.7. Animal Cloning
11.1.8. End-User Applications
11.2. Animal Testing Market By Animal Type
11.2.1. Mice
11.2.2. Rat
11.2.3. Frogs
11.2.4. Fish
11.2.5. Birds
11.2.6. Guinea pig
11.2.7. Hamster
11.2.8. Rabbits
11.2.9. Sheep
11.2.10. Dogs
11.2.11. Cats
11.2.12. Monkeys
11.2.13. Pigs
11.2.14. Others
12. Number Of Animals Used In Research, By Country
12.1.1. USA
12.1.2. Europe
12.1.3. United Kingdom (UK)
12.1.4. Germany
12.1.5. France
12.1.6. Australia
12.1.7. Canada
12.1.8. China
13. Non-Animal Alternative Testing Technologies By Type And End Use
13.1. Introduction
13.2. Types Of Non-Animal Alternative Testing Technologies
13.2.1. Cell Or Tissue Culture (In-Vitro)
13.2.2. Major Cell Culture Developers Worldwide
13.2.3. Organ-On-Chip (OOC)
13.2.4. Global OOC Market Size And Growth
13.2.5. Global OOC Market Drivers And Restraints
13.2.6. Market Drivers
13.2.7. Market Restraints
13.2.8. In-silico (Computer-Based Models)
13.2.9. Artificial Skin Models (Skin Substitutes)
13.2.10. Other Technologies
14. End-User Industries Adoption To Alternative Testing Technologies
14.1.Adoption of Alternative Testing Technologies By Type of Industry
14.1.1. Cosmetics Industry
14.1.2. Pharmaceutical Industry
14.1.3. Medical Device Industry
14.1.4. Others
14.2. Adoption of 3R’s In USA
14.2.1. 3R Adoption In The Cosmetics Industry
14.2.2. 3R Adoption In The Pharmaceutical Industry
14.2.3. 3R Adoption In The Medical Device Industry
14.3.Adoption of 3R’s In China
14.3.1. 3R Adoption In The Cosmetics Industry
14.3.2. 3R Adoption In The Pharmaceutical Industry
14.3.3. 3R Adoption In The Medical Device Industry
14.4. Adoption of 3R’s In Europe
14.4.1. 3R Adoption In The Cosmetics Industry
14.4.2. 3R Adoption In The Pharmaceutical Industry
14.4.3. 3R Adoption In The Medical Device Industry
15. Global Animal Testing And Non-Animal Testing Market
15.1. Global Animal Testing Market Size And Growth
15.1.1. Global Animal Testing Market Value ($ Billion)
15.1.2. Global Animal Testing Market, By Volume (Million Units)
15.1.3. Drivers Of The Animal Testing Market
15.1.4. Restraints On The Animal Testing Market
15.2. Global Non-Animal Alternative Testing Market Size And Growth
15.2.1. Global Non-Animal Alternative Testing Market Value ($ Billion)
15.2.2. Drivers Of The Non-Animal Alternative Testing Market
15.2.3. Restraints On The Non-Animal Alternative Testing Market
16. Animal Testing And Non-Animal Testing Market, Regional And Country Analysis
17. USA Animal Testing And Non-Animal Alternative Testing Market
17.1. USA Animal Testing Market
17.1.1. USA Animal Testing Market Value ($ Billion)
17.1.2. USA Animal Testing Market, By Volume (Million Units)
17.2. USA Non-Animal Alternative Testing Market
17.2.1. USA Non-Animal Alternative Testing Market Value ($ Billion)
17.3. USA Animal Testing Market By End Use Industrial Application
17.3.1. Market By Value And Volume
17.3.2. Pharmaceuticals
17.3.3. Academic Research industry was the second largest
17.3.4. Medical Devices industry was the third largest
17.3.5. Chemicals And Pesticides industry was the fourth largest
17.3.6. Cosmetics industry was the smallest
17.3.7. Other industries were the fifth largest
17.3.8. Share Of Top 5 Companies, By Revenue (In Each Industrial Application)
17.4. Regulatory Landscape In The USA
17.4.1. Regulatory Bodies & Policies
17.4.2. Proposed Regulations & Guidelines Driving The Animal Testing Alternatives Market
17.4.3. USDA & Animal Welfare Act
17.4.4. ICCVAM
17.4.5. FDA
17.4.6. NIH
18. Japan Animal Testing And Non-Animal Alternative Testing Market
18.1. Japan Animal Testing Market
18.1.1. Japan Animal Testing Market Value ($ Billion)
18.1.2. Japan Animal Testing Market, By Volume (Million Units)
18.2. Japan Non-Animal Alternative Testing Market
18.2.1. Japan Non-Animal Alternative Testing Market Value ($ Billion)
18.3.Japan Animal Testing Market By End Use Industrial Application
18.3.1. Share Of Top 5 Companies, By Revenue (In Each Industrial Application)
18.4. Regulatory Landscape In Japan
18.4.1. Regulatory Bodies & Policies
18.4.2. Proposed Regulations & Guidelines Driving Animal Testing Alternatives Market
18.4.3. Law for the Humane Treatment and Management of Animals
18.4.4. MHLW, MEXT, And MAFF
19. China Animal Testing And Non-Animal Alternative Testing Market
19.1.China Animal Testing Market
19.1.1. China Animal Testing Market Value ($ Billion)
19.1.2. China Animal Testing Market, By Volume (Million Units)
19.2. Regulatory Landscape In China
19.2.1. Regulatory Bodies & Policies
19.2.2. Proposed Regulations & Guidelines Driving Animal Testing Alternatives Market
20. Australia Animal Testing And Non-Animal Alternative Testing Market
20.1. Australia Animal Testing Market
20.1.1. Australia Animal Testing Market Value ($ Billion)
20.1.2. Australia Animal Testing Market, By Volume (Million Units)
20.2. Regulatory Landscape In Australia
20.2.1. Regulatory Bodies & Policies
20.2.2. Proposed Regulations & Guidelines Driving The Animal Testing Alternatives Market
21. Europe Animal Testing And Non-Animal Alternative Testing Market
21.1. Regulatory Landscape In Europe
21.1.1. EU Directive 2010/63
21.2. Europe Non-Animal Alternative Testing Market
21.2.1. Europe Non-Animal Alternative Testing Market Value ($ Billion)
22. France Animal Testing And Non-Animal Alternative Testing Market
22.1. France Animal Testing Market
22.1.1. France Animal Testing Market Value ($ Billion)
22.1.2. France Animal Testing Market, By Volume (Million Units)
22.2. France Animal Testing Market By End Use Industrial Application
22.2.1. Market By Value And Volume
22.2.2. Pharmaceuticals
22.2.3. Academic Research industry was the second largest
22.2.4. Chemicals & Pesticides industry was the third largest
22.2.5. Medical Devices industry was the fourth largest
22.2.6. Cosmetics industry was the smallest
22.2.7. Other industries were the fifth largest
22.3. Regulatory Landscape In France
22.3.1. Regulatory Bodies & Policies
22.3.2. Proposed Regulations & Guidelines Driving The Animal Testing Alternatives Market
23. Germany Animal Testing And Non-Animal Alternative Testing Market
23.1. Germany Animal Testing Market
23.1.1. Germany Animal Testing Market Value ($ Billion)
23.1.2. Germany Animal Testing Market, By Volume (Million Units)
23.2. Germany Animal Testing Market By End Use Industrial Application
23.2.1. Market By Value And Volume
23.2.2. Pharmaceuticals
23.2.3. Academic Research industry was the second largest
23.2.4. Medical Devices industry was the third largest
23.2.5. Chemicals And Pesticides industry was the fifth largest
23.2.6. Cosmetics industry was the smallest
23.2.7. Other industries were the fifth largest
23.3.Regulatory Landscape In Germany
23.3.1. Regulatory Bodies & Policies
23.3.2. Proposed Regulations & Guidelines Driving the Animal Testing Alternatives Market
24. UK Animal Testing And Non-Animal Alternative Testing Market
24.1. UK Animal Testing Market
24.1.1. UK Animal Testing Market Value ($ Billion)
24.1.2. UK Animal Testing Market, By Volume (Million Units)
24.2. UK Animal Testing Market By End Use Industrial Application
24.2.1. Market By Value And Volume
24.2.2. Pharmaceuticals
24.2.3. Academic Research industry was the second largest
24.2.4. Medical Devices industry was the third largest
24.2.5. Chemicals & Pesticides industry was the fifth largest
24.2.6. Cosmetics industry was the smallest
24.2.7. Other industries were the fourth largest
24.3. Regulatory Landscape in United Kingdom (UK)
24.3.1. Regulatory Bodies & Policies
24.3.2. Proposed Regulations & Guidelines Driving the Animal Testing Alternatives Market
25. Canada Animal Testing And Non-Animal Alternative Testing Market
25.1. Canada Animal Testing Market
25.1.1. Canada Animal Testing Market Value ($ Billion)
25.1.2. Canada Animal Testing Market, By Volume (Million Units)
25.2. Regulatory Landscape In Canada
25.2.1. Regulatory Bodies & Policies
25.2.2. Proposed Regulations & Guidelines Driving Animal Testing Alternatives Market
26. Rest Of The World Animal Testing And Non-Animal Alternative Testing Market
26.1. Rest Of The World Animal Testing Market
26.1.1. Rest Of The World Animal Testing Market Value ($ Billion)
26.1.2. Rest Of The World Animal Testing Market, By Volume (Million Units)
26.2. Rest of The World Non-Animal Alternative Testing Market
26.2.1. Rest of The World Non-Animal Alternative Testing Market Value ($ Billion)
26.3. Regulatory Landscape In Rest of the World (RoW)
26.3.1. Regulatory Bodies & Policies
26.3.2. Proposed Regulations & Guidelines Driving Animal Testing Alternatives Market
27. Competitive Landscape For Non-Animal Alternative Technologies
27.1. Company Profiles
27.2. Cyprotex
27.2.1. Company Overview
27.2.2. Products And Services
27.2.3. Business Strategy
27.2.4. Financial Overview
27.3. Bio-Rad Laboratories, Inc.
27.3.1. Company Overview
27.3.2. Products And Services
27.3.3. Business Strategy
27.3.4. Financial Overview
27.4. MatTek Corporation
27.4.1. Company Overview
27.4.2. Products And Services
27.4.3. Business Strategy
27.4.4. Financial Overview
27.5.Emulate, Inc
27.5.1. Company Overview
27.5.2. Products And Services
27.5.3. Business Strategy
27.5.4. Financial Overview
27.6. BioIVT
27.6.1. Company Overview
27.6.2. Products And Services
27.6.3. Business Strategy
27.6.4. Financial Overview
27.7. USA Non-Animal Alternative Testing Market Competitive Landscape
27.7.1. Emulate, Inc
27.7.2. Organovo Holdings, Inc
27.7.3. MatTek Corporation
27.7.4. EMD Millipore
27.8. China Non-Animal Alternative Testing Market Competitive Landscape
27.8.1. China Tissue Engineering Co., Ltd. (J-TEC)
27.8.2. ReproCell Inc
27.8.3. Organ Technologies Co, Ltd
27.9. Europe Non-Animal Alternative Testing Market Competitive Landscape
27.9.1. Episkin
28. Animal Testing And Non Animal Alternative Testing Global Market Opportunities And Strategies
28.1. Global Animal Testing Market In 2035 - Geographies Offering Most New Opportunities
28.2. Global Non-Animal Alternative Testing Market In 2035 - Geographies Offering Most New Opportunities
28.3. Global Animal Testing And Non-Animal Alternative Testing Market In 2035 - Segments Offering Most New Opportunities
28.4. Global Animal Testing And Non-Animal Alternative Testing Market In 2025 - Growth Strategies
28.4.1. Non-Animal Alternative Testing Market Trend Based Strategies
28.4.2. Competitor Strategies
29. Conclusions & Recommendations
29.1. Conclusions
29.2. Recommendations
29.2.1. Product
29.3. Develop 3D-Printed Organs
29.3.1. Price
29.3.2. Place
29.3.3. Promotion
29.3.4. People
29.3.5. Need For Validated Non-Animal Alternatives For Pharma And Other End-Use Industries
29.3.6. Increasing Number Of Players In The Non-Animal Alternative Testing Market
29.3.7. Focus On Developed Countries
29.3.8. Collaborations With Technology Developers And Animal Welfare Organizations For Promotion
30. Appendix
30.1.Glossary
30.2. Market Data Sources
30.3.Research Methodology
30.3.1. OCED Accepted In Vito Tests
30.4. Survey on Animal Models & Testing Landscape in the US
30.4.1. Current Condition By Company
30.4.2. Number Of Animals Used In Testing
30.5. Expert Interviews List
30.6. Non Animal Alternative Testing Interviews
30.7. USA Interviews
30.7.1. Interview 1
30.7.2. Interview 2
30.7.3. Interview 3
30.7.4. Interview 4
30.7.5. Interview 5
30.7.6. Interview 6
30.7.7. Interview 7
30.7.8. Interview 8
30.7.9. Interview 9
30.8. China Interviews
30.8.1. Interview 10
30.8.2. Interview 11
30.8.3. Interview 12
30.8.4. Interview 13
30.8.5. Interview 14
30.8.6. Interview 15
30.9. Animal Testing Interviews
30.9.1. Interview 16
30.9.2. Interview 17
30.9.3. Interview 18
30.9.4. Interview 19
30.9.5. Interview 20
30.9.6. Interview 21
30.9.7. Interview 22
30.9.8. Interview 23

Samples

Loading
LOADING...

Executive Summary

Animal Testing And Non-Animal Alternative Testing Global Market Opportunities And Strategies To 2035 provides the strategists; marketers and senior management with the critical information they need to assess the global animal testing and non-animal alternative testing market as it emerges from the COVID 19 shut down.



Reasons to Purchase:

  • Gain a truly global perspective with the most comprehensive report available on this market covering 8 geographies.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis.

Description:

Where is the largest and fastest growing market for the animal testing and non-animal alternative testing? How does the

Animal Testing And Non-Animal Alternative Testing Global Market Opportunities And Strategies To 2035 provides the strategists; marketers and senior management with the critical information they need to assess the global animal testing and non-animal alternative testing market as it emerges from the COVID 19 shut down.



Reasons to Purchase:

  • Gain a truly global perspective with the most comprehensive report available on this market covering 8 geographies.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis.

Description:

Where is the largest and fastest growing market for the animal testing and non-animal alternative testing? How does the market relate to the overall economy; demography and other similar markets? What forces will shape the market going forward? The animal testing and non-animal alternative testing market global report answers all these questions and many more.


The report covers market characteristics; size and growth; segmentation; regional and country breakdowns; competitive landscape; market shares; trends and strategies for this market. It traces the market’s historic and forecast market growth by geography. It places the market within the context of the wider animal testing and non-animal alternative testing market; and compares it with other markets.



The report covers the following chapters:

  • Executive Summary - The executive summary section of the report gives a brief overview and summary of the report.
  • Report Structure - This section gives the structure of the report and the information covered in the various sections.
  • Introduction - This section gives the segmentation of the animal testing and non-animal alternative testing market by geography and by type covered in this report.
  • Market Characteristics - This section introduces the market and provides information on market definitions of animal testing and non-animal alternative testing markets.
  • Market Value Chain Analysis - This section gives information on value chain analysis for the animal testing and non-animal alternative testing markets.
  • Non-Animal Alternative Testing Trends - This chapter describes the major trends shaping the global non-animal alternative testing market. This section highlights likely future developments in the market and suggests approaches companies can take to exploit these opportunities.
  • Cost Analysis For Animal Testing and Alternative Technologies - This section describes the comparative cost analysis for animal testing and alternative methods to understand the cost-effectiveness and time efficiency of alternative methods. It includes the average cost of animal species and the cost of alternatives to conventional animal testing methods.
  • Animal Testing And Non-Animal Alternative Testing By Type And End Use - This section describes the overview of the types of non-animal alternative testing technologies. It also highlights the major developers and end-use industries in non-animal alternative testing technologies in the major geographies.
  • End-User Industries Adoption To Alternative Technologies - This section details information on the adoption of alternative technologies by top end-use industries in the USA, Germany, France, UK, and Japan. This section also includes the adoption of 3R principles by each of the top industries in the USA, China, and Europe.
  • Global Animal Testing Market Size - This section provides information on the global animal testing market by value and volume for the current and forecast period (2019-2035) and the drivers and restraints that support and restrain the growth of the market during this period.
  • Global Non-Animal Alternative Testing Market Size - This section provides information on the global non-animal alternative testing market size for the current and forecast period (2019-2035) and the drivers and restraints that support and restrain the growth of the market during this period.
  • Animal Testing And Non Animal Testing Market Regional And Country Analysis - This section contains the animal testing market by value and volume, and non-animal alternative testing market by value for the major geographies for the current and forecast period (2019-2035). This section also provides end-use industries segmentation in animal alternative testing in the major geographies.
  • Animal Testing Regulatory Landscape - This section describes the regulatory landscape for animal testing and its alternatives in major geographies. It includes information on regulatory agencies and policies governing animal testing. This section also includes the proposed regulations and guidelines that are driving the non-animal alternative testing technologies market in major geographies.
  • Competitive Landscape For Alternative Technologies - This section briefs information on major companies involved in the alternative technology market in the USA, China, and Europe. This section includes the profiles of the major alternative technology developers with information on their product portfolio, financial analysis, and strategies implemented by these companies.
  • Market Opportunities And Strategies- This section includes market opportunities and strategies based on findings of the research. This section also gives information on growth opportunities across countries, segments and strategies to be followed in those markets. It gives an understanding of where there is significant business to be gained by competitors in the next five years.
  • Conclusions And Recommendations - This section includes conclusions and recommendations based on findings of the research. This section also gives recommendations for animal testing and non-animal alternative testing providers in terms of product/service offerings, geographic expansion, marketing strategies and target groups.
  • Appendix - This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report.

Scope:


Markets Covered:


  1. 1) By End User Industry: Pharmaceuticals; Academic Research; Medical Devices; Chemicals And Pesticides; Cosmetics; Others
  2. 2) By Animal Type: Mice; Rat; Frogs; Fish; Birds; Guinea pig; Hamster; Rabbits; Sheep; Dogs; Cats; Monkeys; Pigs; Others

Companies Mentioned:

Cyprotex; Bio-Rad Laboratories, Inc.; MatTek Corporation; Emulate, Inc; BioIVT


Countries:

Australia; China; France; Germany; Japan; UK; USA; Canada


Regions:

Asia-Pacific; Europe; North America; Rest Of The World


Time series:

Five years historic and ten years forecast.


Data:

Ratios of market size and growth to related markets; GDP proportions; expenditure per capita; animal testing and non-animal alternative testing indicators comparison.


Data segmentations:

country and regional historic and forecast data; market share of competitors; market segments.


Sourcing and Referencing:

Data and analysis throughout the report is sourced using end notes.

Companies Mentioned

A selection of companies mentioned in this report includes:

  • Cyprotex
  • Bio-Rad Laboratories, Inc.
  • MatTek Corporation
  • Emulate, Inc.
  • BioIVT

Methodology

Loading
LOADING...